Brief: Soligenix Reports 2022 Loss Per Share Of $4.81

Soligenix

31/03/2023 12:36

March 31 (Reuters) - Soligenix Inc  SNGX.O :
    * SOLIGENIX INC FY LOSS PER SHARE $4.81
    * SOLIGENIX -  PREPARING FOR TYPE A MEETING WITH FDA TO
DISCUSS
CONTENTS OF RTF LETTER ISSUED BY FDA TO CO'S NDA FOR HYBRYTE
SUBMITTED IN DECEMBER 2022
    * SOLIGENIX INC - ANTICIPATE CLINICAL STUDY RESULTS IN
SECOND HALF
OF 2023 FOR SGX302
    * SOLIGENIX INC - CONTINUE TO ASSESS ALL STRATEGIC OPTIONS

Source text for Eikon:  ID:nPn7zJZnja 
Further company coverage:  SNGX.O 

 ((Reuters.Briefs@thomsonreuters.com;))